Today: 13 July 2026
Oracle Stock’s $638 Billion Order Book Faces a $42 Billion Cash Test
12 July 2026
3 mins read

Oracle Stock’s $638 Billion Order Book Faces a $42 Billion Cash Test

New York, July 12, 2026, 17:17 EDT

Oracle Corporation heads into Monday with one market question: can its AI-driven order book turn into cash fast enough to offset the debt and stock needed to build data centers? The market’s answer, for now, is no. Oracle closed Friday at $140.64, down 2.48%; even after crediting its $0.50 quarterly dividend to the day’s return, the loss was about 2.14%. A cut to BBB-, the lowest investment-grade rating rung, has made funding — not demand — the next price driver.

Wall Street is shut for the weekend, so Friday’s close is the last read. Oracle gained just 0.26% in the week ended July 10, against 1.23% for the S&P 500 and 1.74% for the Nasdaq Composite. On Friday alone, Oracle fell while the information-technology sector rose 1.65%, a gap that points to company-specific selling rather than a broad retreat from AI.

PerformanceOracleS&P 500Nasdaq Composite
Week ended July 10+0.26%+1.23%+1.74%
Friday-2.48%+0.42%+0.29%
Friday close$140.647,575.3926,281.61

The rating move sharpened that split. S&P Global Ratings, part of S&P Global Inc. , cut Oracle one notch from BBB and retained a stable outlook, saying the AI infrastructure build was weakening Oracle’s business risk profile. The agency now assumes fiscal 2027 capital spending of $90 billion to $95 billion, versus its earlier $60 billion estimate, and forecasts a free operating cash flow deficit near $42 billion. Free operating cash flow is the cash produced by operations after capital spending.

The operating case remains strong enough to keep the argument alive. Fiscal 2026 revenue rose 17% to $67.4 billion, fourth-quarter cloud-infrastructure revenue climbed 93% to $5.8 billion, and remaining performance obligations reached $638 billion. That last figure — contracted revenue not yet booked as sales — is 9.5 times annual revenue, but free cash flow was negative $23.7 billion. Oracle plans roughly $40 billion of debt and equity financing in fiscal 2027 and guides first-quarter revenue growth at 27%-29%.

Oracle’s funding equationLatest figureInvestor read-through
Remaining performance obligations$638 billionDemand is visible; the timing of cash is not
Order book/FY2026 revenue9.5 timesExceptional coverage, but not immediate liquidity
FY2026 free cash flow-$23.7 billionData-center construction consumed cash
Planned FY2027 financingAbout $40 billionOutside capital remains central to the plan
S&P FY2027 cash-flow forecastNearly -$42 billionCredit pressure may persist through the buildout

Chief Executive Clay Magouyrk said Oracle signed “$67 billion in AI infrastructure contracts this quarter” and that prepaid or customer-supplied hardware tied to large AI deals totaled $75 billion. That support matters. It reduces Oracle’s own hardware bill, but it does not erase construction, power and delivery risk. Oracle Blogs

The cleaner investor signal is the 95% ratio: Oracle’s planned fiscal 2027 financing is about 95% of S&P’s projected cash deficit. This is not a liquidity-shortfall forecast — Oracle has customer prepayments and other cash sources — but the near one-for-one scale shows why more bookings alone may no longer lift the stock. What happens next depends on whether each dollar of contracted demand requires less outside capital.

A smaller catalyst arrives Monday, July 13, in Britain. Regulators will begin direct oversight of Oracle, Microsoft Corp. , Amazon.com Inc. and Alphabet Inc.’s Google as critical suppliers to finance, requiring resilience tests, self-assessments and major-incident reports. The move underlines how central the four clouds have become, though added compliance work is unlikely to settle Oracle’s funding argument.

But the risk case can worsen quickly. A slip in data-center delivery or slower customer take-up would delay revenue while interest and construction bills keep running; persistently high rates could raise borrowing costs, while further stock issuance would reduce existing holders’ percentage ownership. The upside is also measurable: meet the first-quarter growth guide and narrow the cash deficit faster than S&P expects.

The first test is macro: U.S. consumer-price data arrive Tuesday, July 14, producer prices Wednesday and retail sales Thursday, while Federal Reserve Chair Kevin Warsh is due to testify before Congress. Michael Reynolds, vice president of investment strategy at Glenmede, said markets face “a number of crosscurrents.” Anthony Saglimbene, chief market strategist at Ameriprise Financial Inc. , said hotter inflation could “push odds of a rate increase higher by year end.” For a BBB- borrower with a heavy financing plan, that would matter through higher borrowing costs even if cloud demand holds. Reuters

Friday’s dividend explains only about 14% of Oracle’s $3.58 share-price drop; the rest was an economic loss, and the week’s index lag says investors are pricing the balance sheet rather than doubting AI demand. The next durable upside trigger is cash conversion. Until Oracle proves it, the $638 billion order book and BBB- rating will pull the shares in opposite directions.

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

Stock Market Today

  • IPOs Pick Up in Singapore, Hong Kong as 2026 Progresses—Risks Linger
    July 12, 2026, 7:26 PM EDT. Singapore and Hong Kong IPO activity picked up again, with both markets pushing their status as regional fundraising hubs. Singapore saw S$1.1 billion raised from five new IPOs in H1 2026, reversing the recent dry spell. New stocks cover REITs, tech and event management. Foundation Healthcare just listed on the mainboard, and three more offerings look set to come. Market rules and better liquidity have helped, but instability is still in the picture.
Pfizer (NYSE:PFE) scores FDA approval but Wall Street reaction muted
Previous Story

Pfizer (NYSE:PFE) scores FDA approval but Wall Street reaction muted

Robinhood Stock Eyes New Targets as $848 Million Chain Volume Comes With Revenue Snag
Next Story

Robinhood Stock Eyes New Targets as $848 Million Chain Volume Comes With Revenue Snag

Go toTop